Yahoo Web Search

Search results

1. • 

     Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.

     The Wall Street Journal· 5 days ago

     More patients can fend off the disease for months or years with targeted or immune-boosting drugs,...

2. • 

     Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?

     Investor's Business Daily· 27 minutes ago

     Despite a bevy of promising updates for its cancer treatments, Pfizer stock remains trapped below a...

3. • 

     New Lung Cancer Drug Trial Hailed As Best Result Ever, Setting A “New Benchmark”

     IFLScience· 4 days ago

     Phase III trial results for a new drug targeting advanced lung cancer have just been reported, with...

4. • 

     Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer

     MedPage Today· 5 days ago

     The antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...

5. • Theralase(R) Successfully Destroys Lung Cancer

     Digital Journal· 1 day ago

     cancers, bacteria and viruses, is pleased to announce that it's lead compound, RuvidarTM, combined with transferrin to form the compound Rutherrin®, has been proven effective ...

6. • 

     Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness

     NBC Universal via AOL· 5 days ago

     By attaching a chemotherapy drug to an antibody, doctors are able to deliver more potentcancer...

7. • 

     Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates

     The National Law Review· 2 days ago

     Antibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...

8. • 

     Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial

     WSAU Wausau· 7 days ago

     By Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than ...

9. • 

     Gilead drug fails to confirm its FDA approval in bladder cancer - Silicon Valley Business Journal

     The Business Journals· 7 days ago

     Trodelvy was the centerpiece drug of Gilead's acquisition of Immunomedics Inc. but has had mixed...

10. • Bristol’s $250,000 pill slows lung cancer growth by 7 weeks

      San Francisco Chronicle· 4 days ago

      A Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result ...